| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2cf7f3f36d20185ce15a2d1f04d5fdc1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4833
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7007 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22 |
| filingDate |
2007-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d67f4719b904ca56d313c76196139fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1043003b62cf0cc334acfe8ede1cb066
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b46e63042e608347bb33dc132e3e3999
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1411c30c0817f9d2db281146552d2f5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19792320056beb076a8012205194bb7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32b1088e138e278eb4d2eb4849f8d658 |
| publicationDate |
2009-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20090033342-A |
| titleOfInvention |
Pharmaceutically Acceptable Solubilizing Compositions and Pharmaceutical Dosage Forms Containing the Same |
| abstract |
The present invention comprises (i) at least one tocopheryl compound having a polyalkylene glycol moiety and (ii) at least one alkylene glycol fatty acid mono ester or a mixture of alkylene glycol fatty acid monoesters and alkylene glycol fatty acid diesters. It relates to a pharmaceutically acceptable solubilizing composition. Solubilizing compositions of the invention are useful for preparing pharmaceutical dosage forms comprising a melt treated mixture of one or more active ingredients and one or more pharmaceutically acceptable polymers. The solubilizing composition of the present invention improves the bioavailability of the active ingredient after oral ingestion. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200006259-A |
| priorityDate |
2006-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |